Geron Corporation — Company profile
Healthcare · Biotechnology · United States
Last price 0.9462 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 607.91M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company’s product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.
Details
| Name | Geron Corporation |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 258 |
| Founded | 1990 |
| Ipo Date | 1996-06-30 |
| Ceo | Harout Semerjian |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US3741631036 |
| Cusip | 374163103 |
| Cik | 0000886744 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Harout Semerjian | Chief Executive Officer, President and Director |
| Michelle J. Robertson | EVice President, Chief Financial Officer, Treasurer and Principal Financial and Accounting Officer |
| Dr. Joseph Emile Eid M.D. | Executive Vice President of Research and Development and Chief Medical Officer |
| Ahmed ElNawawi | Executive Vice President and Chief Commercial Officer |
| Shanthakumar Tyavanagimatt | Senior Vice President and Chief Technical Officer |
| Dawn Schottlandt CFA | Senior Vice President of Investor Relations and Corporate Affairs |
| Timothy Williams J.D. | Executive Vice President, Chief Legal Officer and Corporate Secretary |
| Aron Feingold | Vice President of Investor Relations and Corporate Communications |
| Shannon T. Odam | Executive Vice President and Chief People Officer |
| Bryan Ridgell | Senior Vice President of Portfolio and Project Management and Chief of Staff |
Contact
| Address | 919 East Hillsdale Boulevard, Suite 250, Foster City, California 94404, United States |
| Phone | 650 473 7700 |
| Website | https://www.geron.com |